Torstein Øverland

445 total citations
5 papers, 80 citations indexed

About

Torstein Øverland is a scholar working on Molecular Biology, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Torstein Øverland has authored 5 papers receiving a total of 80 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Epidemiology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Torstein Øverland's work include Congenital heart defects research (4 papers), Congenital Heart Disease Studies (4 papers) and Coronary Artery Anomalies (2 papers). Torstein Øverland is often cited by papers focused on Congenital heart defects research (4 papers), Congenital Heart Disease Studies (4 papers) and Coronary Artery Anomalies (2 papers). Torstein Øverland collaborates with scholars based in Norway, United States and Poland. Torstein Øverland's co-authors include Tore G. Abrahamsen, Liv Osnes, Kari Lima, Rolf D. Pettersen, Lars O. Baumbusch, Paul Hoff Backe, Shalini N. Jhangiani, Donna M. Muzny, Robert Lyle and Børre Fevang and has published in prestigious journals such as Scandinavian Journal of Immunology, Journal of Clinical Immunology and Molecular Genetics & Genomic Medicine.

In The Last Decade

Torstein Øverland

5 papers receiving 78 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Torstein Øverland Norway 4 57 22 22 20 11 5 80
Tzu‐Wen Yeh Japan 5 82 1.4× 20 0.9× 35 1.6× 16 0.8× 19 1.7× 5 108
Elena Deripapa Russia 5 48 0.8× 26 1.2× 23 1.0× 16 0.8× 19 1.7× 24 82
Shahnaz Bibi United Kingdom 5 88 1.5× 19 0.9× 37 1.7× 23 1.1× 16 1.5× 11 113
Tiziana Lorenzini Italy 5 73 1.3× 20 0.9× 33 1.5× 20 1.0× 12 1.1× 9 113
Svetlana Sharapova Belarus 6 74 1.3× 17 0.8× 36 1.6× 18 0.9× 6 0.5× 21 98
Nadezhda Camacho-Ordóñez Germany 6 67 1.2× 9 0.4× 30 1.4× 10 0.5× 10 0.9× 8 80
A Gennery United Kingdom 2 78 1.4× 21 1.0× 29 1.3× 16 0.8× 23 2.1× 3 99
Kanako Mitsui‐Sekinaka Japan 6 62 1.1× 11 0.5× 26 1.2× 12 0.6× 21 1.9× 7 82
Yulia Rodina Russia 6 70 1.2× 13 0.6× 33 1.5× 22 1.1× 27 2.5× 20 100
Lauren A. Henderson United States 2 52 0.9× 10 0.5× 19 0.9× 26 1.3× 6 0.5× 2 70

Countries citing papers authored by Torstein Øverland

Since Specialization
Citations

This map shows the geographic impact of Torstein Øverland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Torstein Øverland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Torstein Øverland more than expected).

Fields of papers citing papers by Torstein Øverland

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Torstein Øverland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Torstein Øverland. The network helps show where Torstein Øverland may publish in the future.

Co-authorship network of co-authors of Torstein Øverland

This figure shows the co-authorship network connecting the top 25 collaborators of Torstein Øverland. A scholar is included among the top collaborators of Torstein Øverland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Torstein Øverland. Torstein Øverland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

5 of 5 papers shown
1.
Øverland, Torstein, et al.. (2020). Complement Activation in 22q11.2 Deletion Syndrome. Journal of Clinical Immunology. 40(3). 515–523. 5 indexed citations
2.
Øverland, Torstein, et al.. (2018). Lymphocyte Apoptosis and FAS Expression in Patients with 22q11.2 Deletion Syndrome. Journal of Clinical Immunology. 39(1). 65–74. 2 indexed citations
3.
Sorte, Hanne Sørmo, Liv Osnes, Børre Fevang, et al.. (2016). A potential founder variant inCARMIL2/RLTPRin three Norwegian families with warts, molluscum contagiosum, and T-cell dysfunction. Molecular Genetics & Genomic Medicine. 4(6). 604–616. 45 indexed citations
4.
Øverland, Torstein, Liv Osnes, Lars O. Baumbusch, et al.. (2015). Neonatal Levels of T-cell Receptor Excision Circles (TREC) in Patients with 22q11.2 Deletion Syndrome and Later Disease Features. Journal of Clinical Immunology. 35(4). 408–415. 23 indexed citations
5.
Øverland, Torstein, et al.. (2015). Increased Levels of Interferon‐Inducible Protein 10 (IP‐10) in 22q11.2 Deletion Syndrome. Scandinavian Journal of Immunology. 83(3). 188–194. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026